Dolby Laboratories (DLB) earnings
In the quarter ended June 2026, Dolby Laboratories had revenue of $305M, down 3.3% on a year earlier, and diluted EPS of 0.30.
On July 30, 2026 it reported EPS of 0.43 against an estimate of 0.40 (beat).
The next report is expected on Tuesday, November 17, 2026, with EPS expected around 0.91.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Tue Nov 17, 2026 | — | 0.91 | — |
| Last | Thu Jul 30, 2026 | — | 0.40 | 0.43 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Dolby Laboratories's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $305M | -3.3% | 0.30 | -37.5% | 11.3% | 2026-07-30 |
| Mar 31, 2026 | $396M | +7.1% | 0.99 | +5.3% | 28.5% | 2026-04-30 |
| Dec 31, 2025 | $347M | -2.9% | 0.55 | -21.4% | 17.9% | 2026-01-29 |
| Sep 30, 2025 | $307M | +0.7% | — | — | 9.7% | 2025-11-18 |
| Jun 30, 2025 | $316M | +9.3% | 0.48 | +20.0% | 15.1% | 2025-07-31 |
| Mar 31, 2025 | $370M | +1.4% | 0.94 | -6.9% | 29.2% | 2025-05-01 |
| Dec 31, 2024 | $357M | +13.1% | 0.70 | +1.4% | 22.4% | 2025-01-30 |
| Sep 30, 2024 | $305M | +4.9% | — | — | 15.2% | 2024-11-19 |
| Jun 30, 2024 | $289M | -3.2% | 0.40 | +135.3% | 12.7% | 2024-08-07 |
| Mar 31, 2024 | $365M | -3.0% | 1.01 | +3.1% | 29.9% | 2024-05-02 |
| Dec 31, 2023 | $316M | -5.8% | 0.69 | -15.9% | 21.0% | 2024-02-02 |
| Sep 30, 2023 | $291M | +4.4% | — | — | -1.2% | 2023-11-17 |
Questions
When does Dolby Laboratories report earnings?
Dolby Laboratories's next earnings report is expected on November 17, 2026.
How did Dolby Laboratories do last quarter?
In the quarter ended June 2026, Dolby Laboratories had revenue of $305M, down 3.3% on a year earlier, and diluted EPS of 0.30.
From Dolby Laboratories's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.